Article in Journal of fungi (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors.
Sofía Carla AngioliniLaboratory of Innate Immunity to Fungal Pathogens, Department of Clinical Biochemistry, Faculty of Chemical Sciences, National University of Córdoba, Córdoba 5000, Argentina.ORCID 0000-0001-9242-975X
Emilse RodriguezLaboratory of Innate Immunity to Fungal Pathogens, Department of Clinical Biochemistry, Faculty of Chemical Sciences, National University of Córdoba, Córdoba 5000, Argentina.ORCID 0000-0002-4100-8506
Clarisa Manzone-RodriguezCenter for Research in Clinical Biochemistry and Immunology, CIBICI-CONICET, National University of Córdoba, Córdoba 5000, Argentina.
Paula Alejandra IcelyLaboratory of Innate Immunity to Fungal Pathogens, Department of Clinical Biochemistry, Faculty of Chemical Sciences, National University of Córdoba, Córdoba 5000, Argentina.ORCID 0000-0002-0457-7523
María Soledad MiróLaboratory of Innate Immunity to Fungal Pathogens, Department of Clinical Biochemistry, Faculty of Chemical Sciences, National University of Córdoba, Córdoba 5000, Argentina.ORCID 0009-0009-6671-5053
Fernando Oscar RieraResearch Group of Immunology and Mycology, Córdoba 5000, Argentina.ORCID 0000-0002-0618-1899
Pablo IribarrenCenter for Research in Clinical Biochemistry and Immunology, CIBICI-CONICET, National University of Córdoba, Córdoba 5000, Argentina.ORCID 0000-0002-5679-4386
Juan Pablo CaeiroResearch Group of Immunology and Mycology, Córdoba 5000, Argentina.ORCID 0000-0001-6172-1395
Claudia Elena SotomayorLaboratory of Innate Immunity to Fungal Pathogens, Department of Clinical Biochemistry, Faculty of Chemical Sciences, National University of Córdoba, Córdoba 5000, Argentina.ORCID 0000-0003-2449-0852
Funding
Agencia Nacional de Promoción Científica y Tecnológica- FONCyT . Argentina PICT-2019-2012Agencia Nacional de Promoción Científica y Tecnológica- FONCyT . Argentina PICT 2021 00333AltaMed Health Service Corporation (USA) SNConsejo Nacional de Investigaciones Cientificas y Tecnologicas- CONICET, Argentina PIP 11220220100579COSecretaria de Ciencia y Tecnología, Universidada Nacional de Córdoba, Argentina Secyt-UNC 30720150100934CBSecretaria de Ciencia y Tecnología, Universidada Nacional de Córdoba, Argentina SecyT- UNC 33620230100340CB
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Biphasic Regulation of Epithelial Antimicrobial Peptides During · full record | OpenQuestion